Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
30.03.2017 22:42:00

Global Drug Discovery Market Forecast 2016-2024

LONDON, March 30, 2017 /PRNewswire/ -- KEY FINDINGS
The global drug discovery market is projected to grow from $33997million in 2016 to $68683 million by 2024 growing at a CAGR of 9.19% during the forecast period. Major health disorders such as genetic disorders, mental health disorders, diabetes, cardiovascular and other diseases and their prevalence rates among the population drives the market.

MARKET INSIGHTS
The drug discovery market is segmented on the basis of technology and geography. The drug discovery market on the basis of technology is segmented into QPCR, DNA microarrays, protein microarrays, high-throughput screening, mass spectrometry, gel electrophoresis, chromatography, protein and nucleic acid isolation and other technologies. The drug discovery market by geography is segmented into North America, Europe, Asia-Pacific and Rest of the world.
The major market drivers for the growth of drug discovery market are aging population, increased expenditure on healthcare, and rise in lifestyle oriented diseases and fatalities. Contrarily, the delayed processing of government regulations, poor access to the healthcare services and the shift from branded drugs to generic drugs are factors that restraints the market growth.

REGIONAL INSIGHTS
North America holds a colossal market share in the global drug discovery market. NA also accounts for highest consumer of branded drugs. Europe accounts for the second largest market in the global drug discovery market. Asia-Pacific market is projected to grow during the forecast period due to increase in the number of contract research organizations in the region.

COMPETITIVE INSIGHTS
The leading players in the drug discovery market are Johnson And Johnson, Bayer AG Sanofi, AstraZeneca PLC, Pfizer, Merck & Co. INC., Boehringer Ingelheim, INC., Glaxosmithkline LLC, Eli Lily, Roche Holding AG. Sanofi, formerly Sanofi-Aventis.

Download the full report: https://www.reportbuyer.com/product/4796849/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-drug-discovery-market-forecast-2016-2024-300432212.html

SOURCE ReportBuyer

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!